Treace Medical Concepts, Inc.
TMCI
$2.84
$0.010.18%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 7.90% | 7.67% | 7.54% | 11.89% | 16.14% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.90% | 7.67% | 7.54% | 11.89% | 16.14% |
| Cost of Revenue | 12.00% | 10.74% | 11.74% | 16.80% | 20.16% |
| Gross Profit | 6.91% | 6.93% | 6.56% | 10.75% | 15.21% |
| SG&A Expenses | -2.40% | -4.01% | 1.26% | 8.21% | 17.83% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 0.43% | -0.72% | 4.12% | 11.09% | 18.99% |
| Operating Income | 23.90% | 26.34% | 7.72% | -8.18% | -29.34% |
| Income Before Tax | 18.55% | 22.77% | 3.21% | -12.55% | -29.09% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 18.55% | 22.77% | 3.21% | -12.55% | -29.09% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 18.55% | 22.77% | 3.21% | -12.55% | -29.09% |
| EBIT | 23.90% | 26.34% | 7.72% | -8.18% | -29.34% |
| EBITDA | 30.07% | 32.16% | 12.81% | -3.52% | -25.60% |
| EPS Basic | 19.93% | 23.80% | 4.28% | -10.20% | -25.15% |
| Normalized Basic EPS | 21.60% | 23.87% | 4.36% | -10.13% | -26.15% |
| EPS Diluted | 19.67% | 23.55% | 3.98% | -10.52% | -25.15% |
| Normalized Diluted EPS | 21.60% | 23.87% | 4.36% | -10.13% | -26.15% |
| Average Basic Shares Outstanding | 1.50% | 1.26% | 1.17% | 2.09% | 4.46% |
| Average Diluted Shares Outstanding | 1.50% | 1.26% | 1.17% | 2.09% | 4.46% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |